Registration is open for Eyes On Retina 2026!

Review key findings from clinical trials on the efficacy and safety of low-dose atropine, spectacles, and contact lenses to slow myopia progression.

Join Drs. Barnett and Quint to review practical strategies for optometrists to incorporate dry eye diagnostics and targeted therapies into their practice

In this Q&A, Stephanie Woo, OD, FAAO, FSLS, discusses myopia management with Thanh Mai, OD, FSLS, covering a range of clinical questions and practice strategies.

Promising early results pave the way for a higher-dose cohort; FDA meeting signals potential phase 3 trial in 2027.

Biopharma company secures exclusive U.S. rights to distribute and resell genomic testing and screening program for an initial 1-year term.

Patients with diabetes were more likely to develop corneal ulcers within a year, and the risk climbed higher when blood sugar control worsened.

Sit down with Drs. Singh and Magrath to discuss Opus Genetics’ inherited retinal disease (IRD) programs and the challenges of treating ultra-rare diseases.

Play along with the game EyesUp to find out if you can identify four key variables in contact lens comfort within the time limit.

Sit down with Drs. Dierker and Quint as they discuss practical strategies for implementing clinical insights from DEWS III into everyday practice.

Sit down with Drs. Lang, Garlich, and Dierker to review the impact of direct-to-consumer (DTC) pharmaceutical marketing on eyecare patients.

Discover artificial intelligence (AI)-based platforms that eyecare providers can use to solve workflow problems to improve practice efficiency.

Learn how eyecare practitioners can integrate artificial intelligence (AI) into their contact lens workflows to improve practice efficiency and profitability.